##gff-version 3
##sequence-region Q8IV16 1 184
Q8IV16	UniProtKB	Signal peptide	1	20	.	.	.	Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q8IV16	UniProtKB	Chain	21	151	.	.	.	ID=PRO_0000318208;Note=Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1	
Q8IV16	UniProtKB	Propeptide	152	184	.	.	.	ID=PRO_0000429858;Note=Removed in mature form;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q8IV16	UniProtKB	Domain	63	148	.	.	.	Note=UPAR/Ly6	
Q8IV16	UniProtKB	Compositional bias	25	31	.	.	.	Note=Poly-Glu	
Q8IV16	UniProtKB	Compositional bias	40	50	.	.	.	Note=Poly-Glu	
Q8IV16	UniProtKB	Lipidation	151	151	.	.	.	Note=GPI-anchor amidated glycine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q9D1N2	
Q8IV16	UniProtKB	Glycosylation	78	78	.	.	.	Note=N-linked (GlcNAc...) asparagine;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q8IV16	UniProtKB	Disulfide bond	65	89	.	.	.	Ontology_term=ECO:0000250;evidence=ECO:0000250	
Q8IV16	UniProtKB	Disulfide bond	68	77	.	.	.	Ontology_term=ECO:0000250;evidence=ECO:0000250	
Q8IV16	UniProtKB	Disulfide bond	83	110	.	.	.	Ontology_term=ECO:0000250;evidence=ECO:0000250	
Q8IV16	UniProtKB	Disulfide bond	114	130	.	.	.	Ontology_term=ECO:0000250;evidence=ECO:0000250	
Q8IV16	UniProtKB	Disulfide bond	131	136	.	.	.	Ontology_term=ECO:0000250;evidence=ECO:0000250	
Q8IV16	UniProtKB	Natural variant	14	14	.	.	.	ID=VAR_044503;Note=Polymorphism%3B it may act as a disease modifier contributing to severe HLPP1D when associated with R-68 or F-89%3B results in decreased GPIHBP1 expression at the cell surface%3B does not affect interaction with LPL when associated in cis with R-68 in one individual. C->F;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15489334,ECO:0000269|PubMed:21816778,ECO:0000269|PubMed:23831619;Dbxref=dbSNP:rs11538389,PMID:15489334,PMID:21816778,PMID:23831619	
Q8IV16	UniProtKB	Natural variant	56	56	.	.	.	ID=VAR_044504;Note=Polymorphism%3B no discernible effect on interaction with LPL%2C chylomicrons or APOA5. G->R;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:17883852,ECO:0000269|PubMed:17997385;Dbxref=dbSNP:rs587777636,PMID:17883852,PMID:17997385	
Q8IV16	UniProtKB	Natural variant	65	65	.	.	.	ID=VAR_071881;Note=In HLPP1D%3B does not affect protein expression at the cell surface%3B does not interact with LPL%3B promotes formation of dimers and oligomers severely reducing number of monomers. C->S;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:20026666,ECO:0000269|PubMed:25387803;Dbxref=dbSNP:rs587777638,PMID:20026666,PMID:25387803	
Q8IV16	UniProtKB	Natural variant	65	65	.	.	.	ID=VAR_077634;Note=In HLPP1D%3B does not interact with LPL%3B promotes formation of dimers and oligomers severely reducing number of monomers. C->Y;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:22239554,ECO:0000269|PubMed:25387803;Dbxref=dbSNP:rs587777638,PMID:22239554,PMID:25387803	
Q8IV16	UniProtKB	Natural variant	68	68	.	.	.	ID=VAR_071882;Note=In HLPP1D%3B does not affect protein expression at the cell surface%3B does not interact with LPL%3B promotes formation of dimers and oligomers reducing number of monomers. C->G;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:20026666,ECO:0000269|PubMed:25387803;Dbxref=dbSNP:rs587777639,PMID:20026666,PMID:25387803	
Q8IV16	UniProtKB	Natural variant	68	68	.	.	.	ID=VAR_077635;Note=In HLPP1D%3B unknown pathological significance%3B results in decreased GPIHBP1 expression%3B promotes formation of dimers and oligomers severely reducing number of monomers%3B does not affect interaction with LPL when associated in cis with F-14 in one individual. C->R;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:23831619,ECO:0000269|PubMed:25387803;Dbxref=PMID:23831619,PMID:25387803	
Q8IV16	UniProtKB	Natural variant	68	68	.	.	.	ID=VAR_077636;Note=In HLPP1D%3B does not interact with LPL%3B promotes formation of dimers and oligomers severely reducing number of monomers. C->Y;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:21314738,ECO:0000269|PubMed:25387803;Dbxref=PMID:21314738,PMID:25387803	
Q8IV16	UniProtKB	Natural variant	83	83	.	.	.	ID=VAR_077637;Note=In HLPP1D. C->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:27578123;Dbxref=PMID:27578123	
Q8IV16	UniProtKB	Natural variant	89	89	.	.	.	ID=VAR_071883;Note=In HLPP1D%3B drastically affects interaction with LPL%3B promotes formation of dimers and oligomers reducing number of monomers. C->F;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:21816778,ECO:0000269|PubMed:25387803;Dbxref=dbSNP:rs587777640,PMID:21816778,PMID:25387803	
Q8IV16	UniProtKB	Natural variant	108	108	.	.	.	ID=VAR_077638;Note=In HLPP1D%3B does not interact with LPL%3B promotes formation of dimers and oligomers reducing number of monomers. T->R;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:22239554,ECO:0000269|PubMed:25387803;Dbxref=PMID:22239554,PMID:25387803	
Q8IV16	UniProtKB	Natural variant	115	115	.	.	.	ID=VAR_058086;Note=In HLPP1D%3B a patient with chylomicronemia%3B does not affect protein expression at the cell surface%3B does not interact with LPL%3B does not interact with chylomicrons%3B promotes formation of dimers and oligomers reducing number of monomers. Q->P;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:19304573,ECO:0000269|PubMed:22239554,ECO:0000269|PubMed:25387803;Dbxref=dbSNP:rs587777637,PMID:19304573,PMID:22239554,PMID:25387803	
Q8IV16	UniProtKB	Natural variant	144	144	.	.	.	ID=VAR_077639;Note=In HLPP1D. S->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22239554;Dbxref=dbSNP:rs78367243,PMID:22239554	
Q8IV16	UniProtKB	Natural variant	175	175	.	.	.	ID=VAR_071884;Note=In HLPP1D%3B affects protein expression at the cell surface%3B reduces interaction with LPL. G->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21816778;Dbxref=dbSNP:rs145844329,PMID:21816778	
Q8IV16	UniProtKB	Mutagenesis	66	66	.	.	.	Note=Promotes formation of dimers and oligomers reducing number of monomers. Y->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25387803;Dbxref=PMID:25387803	
Q8IV16	UniProtKB	Mutagenesis	71	71	.	.	.	Note=Promotes formation of dimers and oligomers reducing number of monomers. L->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25387803;Dbxref=PMID:25387803	
Q8IV16	UniProtKB	Mutagenesis	91	91	.	.	.	Note=Promotes formation of dimers and oligomers reducing number of monomers. T->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25387803;Dbxref=PMID:25387803	
Q8IV16	UniProtKB	Mutagenesis	92	92	.	.	.	Note=Only slightly increased formation of dimers and oligomers. No effect on number of monomers. Loss of LPL interaction. L->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25387803;Dbxref=PMID:25387803	
Q8IV16	UniProtKB	Mutagenesis	93	93	.	.	.	Note=Promotes formation of dimers and oligomers reducing number of monomers. I->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25387803;Dbxref=PMID:25387803	
Q8IV16	UniProtKB	Mutagenesis	101	101	.	.	.	Note=Promotes formation of dimers and oligomers reducing number of monomers. Retained some interaction with LPL. G->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25387803;Dbxref=PMID:25387803	
Q8IV16	UniProtKB	Mutagenesis	104	104	.	.	.	Note=Promotes formation of dimers and oligomers reducing number of monomers. Retained some interaction with LPL. T->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25387803;Dbxref=PMID:25387803	
Q8IV16	UniProtKB	Mutagenesis	105	105	.	.	.	Note=Promotes formation of dimers and oligomers reducing number of monomers. T->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25387803;Dbxref=PMID:25387803	
Q8IV16	UniProtKB	Mutagenesis	106	106	.	.	.	Note=Promotes formation of dimers and oligomers severely reducing number of monomers. H->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25387803;Dbxref=PMID:25387803	
Q8IV16	UniProtKB	Mutagenesis	107	107	.	.	.	Note=Promotes formation of dimers and oligomers reducing number of monomers. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25387803;Dbxref=PMID:25387803	
Q8IV16	UniProtKB	Mutagenesis	108	108	.	.	.	Note=Retained some interaction with LPL. No effect on number of monomers. T->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25387803;Dbxref=PMID:25387803	
Q8IV16	UniProtKB	Mutagenesis	109	109	.	.	.	Note=Promotes formation of dimers and oligomers reducing number of monomers. Loss of LPL interaction. W->C%2CP%2CT;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25387803;Dbxref=PMID:25387803	
Q8IV16	UniProtKB	Mutagenesis	109	109	.	.	.	Note=Only slightly increased formation of dimers and oligomers. No effect on number of monomers. Loss of LPL interaction. W->S%2CY%2CH%2CA%2CF;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25387803;Dbxref=PMID:25387803	
Q8IV16	UniProtKB	Mutagenesis	115	115	.	.	.	Note=No effect on number of monomers. Q->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25387803;Dbxref=PMID:25387803	
Q8IV16	UniProtKB	Mutagenesis	126	126	.	.	.	Note=Promotes formation of dimers and oligomers reducing number of monomers. V->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25387803;Dbxref=PMID:25387803	
